Literature DB >> 31467942

Biomarker Differences between Controlled and Uncontrolled Hypertension among US Adults: National Health and Nutrition Examination Survey 2005-2010.

Jung Hye Sung1, Jae Eun Lee2, Ji-Young Lee3.   

Abstract

This study aims to determine biomarker differences between controlled and uncontrolled hypertension using nationally representative samples. Those in the uncontrolled hypertension group were more likely to have CVD (p=0.0258) and diabetes (p=0.0004), less likely to meet the recommended waist circumference (p=0.0039) and BMI (p=0.0209), and less likely to drink alcohol (p=0.0002) than those in the controlled hypertension group, after controlling for demographic variables. Upon controlling for demographic variables, risk factors and diseases related to hypertension, those in the uncontrolled hypertension group had higher total cholesterol (p<.0001), HDL (p=0.0702, marginally significant), LDL (p<.0001), triglycerides (p=0.0702, marginally significant), apolipoprotein B (p<.0001), transferrin receptor (p=0.0692, marginally significant), and ACR (p<.0001) than those in the controlled hypertension group.
CONCLUSION: Our study found that ACR, total cholesterol, HDL, LDL, triglycerides, apolipoprotein B, and transferrin receptor are biomarkers associated with the risk of uncontrolled hypertension compared to controlled hypertension. Since uncontrolled hypertension is linked to very high risks of cardiovascular disease and chronic kidney disease, our findings may provide a partial answer to why antihypertensive treatment is ineffective for certain groups of patients. Further studies are warranted to examine the cause of uncontrolled hypertension.

Entities:  

Keywords:  ACR; Biomarker; Transferrin receptor; Uncontrolled Hypertension

Year:  2018        PMID: 31467942      PMCID: PMC6715317     

Source DB:  PubMed          Journal:  Int J Adv Res Sci Eng Technol        ISSN: 2350-0328


  27 in total

Review 1.  Epidemiology of uncontrolled hypertension in the United States.

Authors:  Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

Review 2.  Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?

Authors:  Seema Basi; Pierre Fesler; Albert Mimran; Julia B Lewis
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

3.  Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

4.  Association of an apolipoprotein B gene marker with essential hypertension.

Authors:  P M Frossard; E N Obineche; G G Lestringant
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

5.  Multiple biomarkers and the risk of incident hypertension.

Authors:  Thomas J Wang; Philimon Gona; Martin G Larson; Daniel Levy; Emelia J Benjamin; Geoffrey H Tofler; Paul F Jacques; James B Meigs; Nader Rifai; Jacob Selhub; Sander J Robins; Christopher Newton-Cheh; Ramachandran S Vasan
Journal:  Hypertension       Date:  2007-01-22       Impact factor: 10.190

6.  Iron deficiency is common in idiopathic pulmonary arterial hypertension.

Authors:  G Ruiter; S Lankhorst; A Boonstra; P E Postmus; S Zweegman; N Westerhof; W J van der Laarse; A Vonk-Noordegraaf
Journal:  Eur Respir J       Date:  2010-09-30       Impact factor: 16.671

7.  Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension.

Authors:  V A Boulatov; A Stenehjem; I Os
Journal:  Am J Hypertens       Date:  2001-04       Impact factor: 2.689

8.  Increased serum ferritin is common in men with essential hypertension.

Authors:  Alberto Piperno; Paola Trombini; Marisa Gelosa; Viviana Mauri; Valeria Pecci; Anna Vergani; Alessandra Salvioni; Raffaella Mariani; Giuseppe Mancia
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

Review 9.  Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults.

Authors:  Anne E Sumner
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

Review 10.  The role of metabolites and metabolomics in clinically applicable biomarkers of disease.

Authors:  Mamas Mamas; Warwick B Dunn; Ludwig Neyses; Royston Goodacre
Journal:  Arch Toxicol       Date:  2010-10-16       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.